Stock Analysis

Will Weakness in Revenio Group Oyj's (HEL:REG1V) Stock Prove Temporary Given Strong Fundamentals?

Source: Shutterstock

Revenio Group Oyj (HEL:REG1V) has had a rough three months with its share price down 13%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. Specifically, we decided to study Revenio Group Oyj's ROE in this article.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

View our latest analysis for Revenio Group Oyj

How Do You Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Revenio Group Oyj is:

24% = €22m ÷ €91m (Based on the trailing twelve months to December 2022).

The 'return' is the amount earned after tax over the last twelve months. Another way to think of that is that for every €1 worth of equity, the company was able to earn €0.24 in profit.

What Has ROE Got To Do With Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.

Revenio Group Oyj's Earnings Growth And 24% ROE

First thing first, we like that Revenio Group Oyj has an impressive ROE. Second, a comparison with the average ROE reported by the industry of 8.9% also doesn't go unnoticed by us. Under the circumstances, Revenio Group Oyj's considerable five year net income growth of 26% was to be expected.

We then performed a comparison between Revenio Group Oyj's net income growth with the industry, which revealed that the company's growth is similar to the average industry growth of 26% in the same period.

HLSE:REG1V Past Earnings Growth March 16th 2023

Earnings growth is an important metric to consider when valuing a stock. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. What is REG1V worth today? The intrinsic value infographic in our free research report helps visualize whether REG1V is currently mispriced by the market.

Is Revenio Group Oyj Making Efficient Use Of Its Profits?

The high three-year median payout ratio of 53% (implying that it keeps only 47% of profits) for Revenio Group Oyj suggests that the company's growth wasn't really hampered despite it returning most of the earnings to its shareholders.

Moreover, Revenio Group Oyj is determined to keep sharing its profits with shareholders which we infer from its long history of paying a dividend for at least ten years. Existing analyst estimates suggest that the company's future payout ratio is expected to drop to 39% over the next three years. However, the company's ROE is not expected to change by much despite the lower expected payout ratio.


On the whole, we feel that Revenio Group Oyj's performance has been quite good. Especially the high ROE, Which has contributed to the impressive growth seen in earnings. Despite the company reinvesting only a small portion of its profits, it still has managed to grow its earnings so that is appreciable. Having said that, the company's earnings growth is expected to slow down, as forecasted in the current analyst estimates. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

Valuation is complex, but we're helping make it simple.

Find out whether Revenio Group Oyj is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis


Revenio Group Oyj

Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally.

Excellent balance sheet with solid track record.